Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of “Moderate Buy” by Brokerages
Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective […]
Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective […]
